Telcon RF Pharmaceutical (200230): Korean Health Care stock

What the company does

Telcon RF Pharmaceutical is a South Korean health-care company operating in the pharmaceuticals space, listed on KOSDAQ, Korea's technology and small-cap stock exchange.

The filing's table of contents references both pharmaceutical products and research and development activity, suggesting it supplies medicines or related health-care products to patients or health-care providers. The filing does not provide sufficient product-level detail to identify a single dominant product line or structural business fact beyond its pharmaceutical focus.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$31.3M

▲ +14.0% YoY

Operating profit · FY2025

US$520.7K

Turned profitable

Net income · FY2025

−US$8.3M

Loss narrowed

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$26.3M(₩36.3B)	US$27.4M(₩37.9B)	US$31.3M(₩43.2B)
Operating profit	US$699.5K(₩965.3M)	−US$51.1K(−₩70.5M)	US$520.7K(₩718.6M)
Net income	US$10.1M(₩13.9B)	−US$19.2M(−₩26.5B)	−US$8.3M(−₩11.4B)

Revenue

FY2023US$26.3M
FY2024US$27.4M
FY2025US$31.3M

Operating profit

FY2023US$699.5K
FY2024−US$51.1K
FY2025US$520.7K

Net income

FY2023US$10.1M
FY2024−US$19.2M
FY2025−US$8.3M

Key ratios (FY2025)

ROE

-10.5%

Debt/Eq

44.0%

Op. margin

1.7%

Net margin

-26.5%

Rev. YoY

▲ +14.0%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?